Patents by Inventor Iart Luca Shytaj

Iart Luca Shytaj has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COBICISTAT FOR PREVENTION AND/OR TREATMENT OF CORONAVIRUS INFECTIONS
    Publication number: 20230107186
    Abstract: The present invention relates to cobicistat and its derivatives or prodrugs for use in the prophylaxis and/or treatment of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection, severe acute respiratory syndrome coronavirus (SARS-CoV) infection and/or Middle East respiratory syndrome coronavirus (MERS-CoV) infection. The present invention further relates to methods of prevention and/or treatment of SARS-CoV-2 infection.
    Type: Application
    Filed: March 5, 2021
    Publication date: April 6, 2023
    Inventors: MOHAMED OMAR FARES, MAHMOUD MOSTAFA TOLBA, AHMED TAHA AYOUB, MARINA LUSIC, IART LUCA SHYTAJ, ANDREA SAVARINO, RICARDO SOBHIE DIAZ
  • BUTHIONINE SULFOXIMINE AND A METALLODRUG FOR THE TREATMENT OF CANCER, HIV OR A RHEUMATIC DISEASE
    Publication number: 20210308085
    Abstract: There is disclosed buthionine sulfoximine (BSO) for use in a method of treatment of cancer, HIV or a rheumatic disease. The method comprises administering (a) BSO at a dosage of less than or equal to 50 mg/kg, and (b) a metallodrug at a clinically-acceptable dosage.
    Type: Application
    Filed: June 18, 2021
    Publication date: October 7, 2021
    Inventors: Iart Luca Shytaj, Shailendra Pratap Singh Rathore, Francesco Procopio, Andrea Savarino
  • Buthionine sulfoximine and a metallodrug for the treatment of cancer, HIV or a rheumatic disease
    Patent number: 11065221
    Abstract: There is disclosed buthionine sulfoximine (BSO) for use in a method of treatment of cancer, HIV or a rheumatic disease. The method comprises administering (a) BSO at a dosage of less than or equal to 50 mg/kg, and (b) a metallodrug at a clinically-acceptable dosage.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: July 20, 2021
    Assignee: ISTITUTO SUPERIORE DI SANITÀ
    Inventors: Iart Luca Shytaj, Shailendra Pratap Singh Rathore, Francesco Procopio, Andrea Savarino
  • BUTHIONINE SULFOXIMINE AND A METALLODRUG FOR THE TREATMENT OF CANCER, HIV OR A RHEUMATIC DISEASE
    Publication number: 20200022937
    Abstract: There is disclosed buthionine sulfoximine (BSO) for use in a method of treatment of cancer, HIV or a rheumatic disease. The method comprises administering (a) BSO at a dosage of less than or equal to 50 mg/kg, and (b) a metallodrug at a clinically-acceptable dosage.
    Type: Application
    Filed: March 23, 2018
    Publication date: January 23, 2020
    Applicant: ISTITUTO SUPERIORE DI SANITÀ
    Inventors: Iart Luca Shytaj, Shailendra Pratap Singh Rathore, Francesco Procopio, Andrea Savarino